Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2026-03-09 @ 8:18 AM
Study NCT ID:
NCT02084056
Status:
COMPLETED
Last Update Posted:
2016-08-04
First Post:
2014-03-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/1000mg) Extended Release in Healthy Subjects.
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-04
Start Date Type:
None
Primary Completion Date:
2014-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-07
Completion Date Type:
ACTUAL
First Submit Date:
2014-03-07
First Submit QC Date:
None
Study First Post Date:
2014-03-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-06-23
Results First Submit QC Date:
None
Results First Post Date:
2016-08-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-06-23
Last Update Post Date:
2016-08-04
Last Update Post Date Type:
ESTIMATED